In this paragraph, we will provide an overview of these strategies and we will finally focus on the CMT1A neuropathy, due to the PMP22 gene duplication, the most frequent mutation in CMT that accounts for 50–60% of all CMTs. The gene discussed is PMP22; the disease is Charcot-Marie-Tooth disease type 1A.